GIGiovanni Introcaso

Giovanni Introcaso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giovanni Introcaso has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A challenging laboratory case due to inappropriate sampling through an antiseptic barrier cap

    by Fabio Bottari, Sabrina Frisoli, Giorgia Mandelli, Giorgia Piras, Giovanni Introcaso

    Antiseptic barrier caps are currently used as novel tools in critically ill patients to achieve sterility of the blood sampling site and to prevent central line-associated bloodstream infections in the intensive care unit. A clinical and laboratory case of analytical interferences on erythrocytes, platelets and leukocytes due to the isopropyl alcohol contained in the antiseptic barrier cap is described. An aged man with history of heart valve disease was monitored for hematological parameters after surgery of mitral and tricuspid valve replacement. Leukocyte scattergrams changes on the Sysmex XN 2000 analyzer with the suspicion of platelet clumps were observed. After investigation on sampling procedure, antiseptic barrier cap of an arterial access (BD PureHub disinfecting cap) was used. Another sample has been requested, and the analysis of complete blood count and peripheral blood smear confirmed the presence of clumped microerythrocytes and erythrocytes with damaged membranes. In addition, differential leukocyte count revealed an overestimation of eosinophils by 10%. A new sample taken from venous access provided accurate results without alterations. The preanalytical error generated during blood sampling highlights the importance of correct use of biomedical devices. Furthermore, hematology analyzer technology represents a promising tool for assessing sample quality.

  • Open Access

    High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID‐19 diagnosis?

    by Giovanni Introcaso, Alice Bonomi, Laura Salvini, Tiziana D’errico, Annalisa Cattaneo, Emilio Assanelli, Silvia Stella Barbieri, Maria Luisa Biondi

    Introduction Health professions are heavily engaged facing the current threat of SARS-CoV-2 (COVID-19). Although there are many diagnostic tools, an accurate and rapid laboratory procedure for diagnosing COVID-19 is recommended. We focused on platelet parameters as the additional biomarkers for clinical diagnosis in patients presenting to the emergency department (ED). Materials and Methods Five hundred and sixty-one patients from February to April 2020 have been recruited. Patients were divided into three groups: (N = 50) COVID-19 positive and (N = 21) COVID-19 negative with molecular testing, (N = 490) as reference population without molecular testing. A Multiplex rRT-PCR from samples collected by nasopharyngeal swabs was performed and the hematological data collected. Results We detected a mild anemia in COVID-19 group and lymphopenia against reference population: hemoglobin (g/dL) 13.0 (11.5-14.8) versus 13.9 (12.8-15.0) (P = .0135); lymphocytes (109/L) 1.24 (0.94-1.73) versus 1.99 (1.49-2.64) (P < .0001). In addition, abnormal platelet parameters as follows (COVID group vs reference population): PLT (×109/L) 209 (160-258) vs 236 (193-279) (P = .0239). IPF (%) 4.05 (2.5-5.9) versus 3.4 (2.2-4.9) (P = .0576); H-IPF (%) 1.25 (0.8-2.2) versus 0.95 (0.6-1.5) (P = .0171) were identified. In particular, COVID positive group had a high H-IPF/IPF Ratio compared to reference population [0.32 (0.29-0.36) versus 0.29 (0.26-0.32), respectively, (P = .0003)]. Finally, a PLT difference of nearly 50 × 109/L between pre/postCOVID-19 sampling for each patient was found (N = 42) (P = .0194). Conclusions COVID-19 group results highlighted higher IPF and H-IPF values, with increased H-IPF/IPF Ratio, associated to PLT count reduction. These findings shall be adopted for a timely diagnosis of patients upon hospital admission.


  • Nephrocheck after cardiac surgery: Does it play a role in daily practice? A sequel of “Nephrocheck results should be corrected for dilution”

    by Camilla L’aCqua, Erminio Sisillo, Luca Salvi, Giovanni Introcaso, Maria Luisa Biondi

    Acute kidney injury is a well-recognized complication after cardiac surgery and significantly affects morbidity and mortality. Although the mechanisms of acute kidney injury are not fully understood, Nephrocheck (Astute Medical, San Diego, CA, USA) is a meter for early detection of acute kidney injury based on bedside urinalysis of two cell-cycle arrest biomarkers. However, considerable overlap in the AKIRiskTM score of different RIFLE groups makes interpretation of the score uncertain. A possible reason for the overlap in the AKIRisk score between different RIFLE groups could be that the score is not corrected for dilution. We performed a pilot study to explore the applicability of the test in our daily practice. A total of 68 patients electively scheduled for cardiac surgery with at least two of the following inclusion criteria: age > 70 years, glomerular filtration rate <60 mL/min, left ventricular ejection fraction <41%, redo procedure and combined procedures have been enrolled in the study, and 25 of them developed acute kidney injury. We described the correlation between urine creatinine and Nephrocheck, all the samples with low Nephrocheck (<0.2) also have low urine creatinine, less than 50 mg/dL, detecting a potential diluted sample. In conclusion, in our daily practice AKIRisk score, together with an assessment of whether urine is diluted or concentrated can better discriminate between various degrees of acute kidney injury.


  • Open Access

    Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements in predicting acute kidney injury after cardiac surgery

    by Giovanni Introcaso, Matteo Nafi, Alice Bonomi, Camilla L’acqua, Luca Salvi, Roberto Ceriani, Davide Carcione, Annalisa Cattaneo, Maria Teresa Sandri

    Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements


  • Applicabilità del valore della variazione di riferimento per l’interpretazione di dati ripetuti. L’esempio della troponina I plasmatica nella diagnosi di infarto miocardico acuto

    by Giovanni Introcaso, Monica Raggi

    L’obiettivo di molti studi recenti è stato valutare la differenza critica o il valore della variazione di riferimento (RCV) secondo differenti approcci metodologici; tuttavia, sono richiesti studi di efficacia e di applicabilità diagnostica di Laboratorio. Lo scopo del presente studio è stato verificare l’utilità diagnostica dell’RCV come informazione aggiunta rispetto al metodo di confronto contro la soglia decisionale di infarto miocardico acuto (IMA), in pazienti con sindrome coronarica acuta (SCA). Abbiamo valutato retrospettivamente 40 pazienti ricoverati in reparto di Cardiologia di Emergenza, classificati da esperto staff medico. Sono stati valutati incrementi di cTnI sia tramite il livello decisionale sia tramite l’RCV. L’applicabilità del parametro è stata verificata con uno studio di coorte sugli stessi pazienti valutati con e senza RCV. I due gruppi sono stati analizzati tramite test statistico del chi quadro. I dati ottenuti hanno dimostrato la non significatività tra i due gruppi con e senza RCV, suggerendo la mancanza di valore aggiunto di tale parametro utilizzando un test commerciale per la determinazione della troponina (p=0,51). Il metodo descritto introduce, tuttavia, una novità metodologica, in quanto la variabilità analitica utilizzata nella formula è calcolata da un profilo d’imprecisione. L’RCV, valutato nel presente studio, potrebbe essere utile solo in un numero molto ridotto di pazienti con elevazione di cTnI. The aim of many recent studies was the evaluation of reference change value (RCV) by means of different calculation methods nevertheless the effectiveness and applicability of RCV to routine diagnostics is not yet established. The purpose of present study was to show the possible diagnostic use of RCV for the interpretation of repeated data of troponin I (cTnI) in patients with acute myocardial infarction (AMI). We retrospectively evaluated 40 patients admitted to the emergency cardiology department; they were classified by expert medical staff that compared the increase of cTnI both with decisional cut off for AMI and RCV. The effectiveness of RCV was verified with a cohort study evaluating the patients with and without RCV. We used a test of Chi square for the statistical analysis. Statistical analysis demonstrated the non-significance between the two groups suggesting the lack of added value of RCV calculated using a commercial assay (p=0.51). However, the RCV, calculated with the present method, simplifies the interpretation of repeated data and introduces a methodological novelty in term of the analytical variability used in the formula estimated by a profile of imprecision. The results of cohort study suggest an applicability of RCV in a small number of patients with elevation of cTnI.

  • Open Access

    Short-term increases of plasma cardiac troponin I are better evaluated by comparison with the reference change value

    by Giovanni Introcaso, Monica Raggi, Tiziana D'Errico, Annalisa Cavallero

    Introduction: We have investigated consecutive troponin I measurements using the Reference Change Value (RCV) at low concentrations, in patients admitted in Emergency Department (ED). Materials and methods: Patients admitted for chest pain (N = 103) were evaluated retrospectively on the basis of two consecutive cardiac troponin-I (cTn-I) tests. The second test levels exceeding the “Critical Reference Change Value” (CrRCV), a quantity calculated on the basis of the first result and the RCV of cTn-I, were con-sidered particularly relevant. Clinical cases were analysed matching the concentration change (significative or not) with acute coronary syndrome (clinically confirmed or not). Healthy individuals (N = 70) results and inter-nal quality control results were evaluated for the calculation of, respectively, the biological and the analytical variation of plasma cTn-I. Results: The cTn-I RCV was very high because of the high analytical variation of cTn-I in proximity of its de-cision limit, as shown by its imprecision profile study. Analysing data with the first result < 0.1 µg/L we have obtained an cTn-I RCV negative predictive value - NPV = 88% (95% CI = 82-92%). The 4 groups of patients have demonstrated a clinically significant difference (Chi square test; P < 0.001). Conclusions: The RCV allows to statistically evaluating the cTn-I increased levels in presence of the high im-precision of commercial cTn-I assay at low concentrations. This parameter could be applied in medical practice only for low cTn-I concentrations around the decision limit for the myocardial necrosis.


  • Alveolar Membrane Conductance Decreases as BNP Increases During Exercise in Heart Failure. Rationale for BNP in the Evaluation of Dyspnea

    by Gaia Cattadori, Karlman Wasserman, Chiara Meloni, Saima Mustaq, Mauro Contini, Anna Apostolo, Daniele Andreini, Damiano Magrì, Susanna Sciomer, Fabrizio Veglia, et al.


  • Significance of consecutive international normalized ratio (INR) outcomes using statistical control rules in long-term anticoagulated patients. Optimization of laboratory monitoring and interpretation of borderline measurements

    by Giovanni Introcaso, Giampietro Gesu

    Analysis of serial measurements is needed to elaborate observations in all fields of medical research. In the present study, retrospective data of anticoagulated patients were used to calculate a mean of observations and control limits, X±1σ and X±2σ (mean±standard deviation). During 18 months of coagulation monitoring, 45 patients without major oral anticoagulant therapy complications, with more international normalized ratio (INR) determinations in the therapeutic range and with a normal distribution of INR values according to the Kurtosis coefficient, were selected. The cumulative distribution functions allowed us to obtain critical limits of INR with a cumulative probability (p). Control limits, calculated for a therapeutic control chart, indicated through different control rules, 1S


  • Mathematical Derivative Applied to International Normalised Ratio and Analytical Variations in Oral Anticoagulant Therapy Control

    by G. Introcaso, A. Cuboni, A. Ratto, F. Foieni

    A reliable prothrombin time (PT) testing and a careful drug dosage can prevent thrombotic or bleeding complications of the oral anticoagulant therapy. The international normalised ratio (INR) as PT standardisation introduced an analytical variation that increases with higher PT measures and higher international sensitivity index (ISI) values. Our study was conducted to investigate the INR accuracy through the mathematical derivative application to reduce the analytical component of the INR uncertainty. The evaluation of accuracy among four different systems (prothrombin activity percent, PT seconds, PT ratio and INR) was determined by the simulation of a systematic error. Plasma samples were diluted 1:2; then they were compared observed with the expected values. We analysed the calculation system of the INR through the mathematical derivative in 87 PT ratio measurements. The analytical incidence of thromboplastin ISI was performed through an elaboration of INR mathematical derivative considering 10 different ISI values ranging from 1.1 to 2. The data expressed as PT ratios revealed a lower systematic error propagation suggesting that a linear system is more accurate. According to the calculation formula of INR, analytical variability increases with the PT measurements, then with the intensity of anticoagulation. Mathematical derivative suggests that the INR uncertainty due to the ISI can be reduced using a thromboplastin reagent with a low ISI or with ISI close to 1.